Jeff Yass’s Pasithea Therapeutics Warrants KTTAW Stock Holding History

Jeff Yass’s Portfolio KTTAW Stock Details KTTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216	Buy	+24,293	New	+$170	﹤0.01%	13271
2025 Q4	–	Sell	-14,586	Closed	-$247	–	13032
2025 Q3	$247	Buy	+14,586	New	+$242	﹤0.01%	12225
2025 Q2	–	Sell	-10,579	Closed	-$193	–	13243
2025 Q1	$193	Buy	+10,579	New	+$273	﹤0.01%	12356
2022 Q4	–	Sell	-10,653	Closed	-$2K	–	13095
2022 Q3	$2K	Sell	10,653 -3,150	-23%	-$311	﹤0.01%	12951
2022 Q2	$1K	Buy	+13,803	New	+$1.73K	﹤0.01%	12723

Other funds holding KTTAW

Kepos Capital New York $73.4M AUM 4.78% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Jeff Yass's KTTAW Position: Q2 2026 in Review

Jeff Yass opened a new position in Pasithea Therapeutics Warrants (KTTAW) in Q2 2026: 24,293 shares worth $216. The stake represents ﹤0.01% of the portfolio and ranks #13271 among its holdings. This is a return to the name: Jeff Yass previously reported a position in KTTAW as recently as Q3 2025.

Jeff Yass first reported a position in KTTAW in Q2 2022 and has held it in 5 quarters since. The position peaked at $2K in Q3 2022. 6 funds tracked by Wall St. Rank hold KTTAW as of Q2 2026.

Jeff Yass held 24,293 shares of Pasithea Therapeutics Warrants worth $216 as of Q2 2026.
Pasithea Therapeutics Warrants was a new Jeff Yass position in Q2 2026.
Pasithea Therapeutics Warrants made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13271 holding.
Jeff Yass first reported a position in Pasithea Therapeutics Warrants in Q2 2022 and has held it in 5 quarters since.
Jeff Yass's Pasithea Therapeutics Warrants position peaked at $2K in Q3 2022.
6 funds tracked by Wall St. Rank held Pasithea Therapeutics Warrants as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.